Oncotelic Therapeutics, Inc. (OTLC)

Every official Oncotelic Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Oncotelic Therapeutics, Inc. documents

• Oncotelic Therapeutics, Inc. 10-K 2026OTLC 10-K 2026: annual report for fiscal 2026
• Oncotelic Therapeutics, Inc. 10-K 2025OTLC 10-K 2025: annual report for fiscal 2025
• Oncotelic Therapeutics, Inc. 10-K 2024OTLC 10-K 2024: annual report for fiscal 2024
• Oncotelic Therapeutics, Inc. 10-K 2023OTLC 10-K 2023: annual report for fiscal 2023
• Oncotelic Therapeutics, Inc. 10-K 2022OTLC 10-K 2022: annual report for fiscal 2022
• Oncotelic Therapeutics, Inc. 10-Q 2026OTLC 10-Q 2026: quarterly report for fiscal 2026
• Oncotelic Therapeutics, Inc. 10-Q 2025OTLC 10-Q 2025: quarterly report for fiscal 2025
• Oncotelic Therapeutics, Inc. 10-Q 2024OTLC 10-Q 2024: quarterly report for fiscal 2024
• Oncotelic Therapeutics, Inc. 10-Q 2023OTLC 10-Q 2023: quarterly report for fiscal 2023
• Oncotelic Therapeutics, Inc. 10-Q 2022OTLC 10-Q 2022: quarterly report for fiscal 2022
• Oncotelic Therapeutics, Inc. 8-K 2026OTLC 8-K 2026: current report for fiscal 2026
• Oncotelic Therapeutics, Inc. 8-K 2025OTLC 8-K 2025: current report for fiscal 2025
• Oncotelic Therapeutics, Inc. 8-K 2024OTLC 8-K 2024: current report for fiscal 2024
• Oncotelic Therapeutics, Inc. 8-K 2023OTLC 8-K 2023: current report for fiscal 2023
• Oncotelic Therapeutics, Inc. 8-K 2022OTLC 8-K 2022: current report for fiscal 2022
• Oncotelic Therapeutics, Inc. DEF 14A 2026OTLC DEF 14A 2026: proxy statement for fiscal 2026
• Oncotelic Therapeutics, Inc. DEF 14A 2025OTLC DEF 14A 2025: proxy statement for fiscal 2025
• Oncotelic Therapeutics, Inc. DEF 14A 2024OTLC DEF 14A 2024: proxy statement for fiscal 2024
• Oncotelic Therapeutics, Inc. DEF 14A 2023OTLC DEF 14A 2023: proxy statement for fiscal 2023
• Oncotelic Therapeutics, Inc. DEF 14A 2022OTLC DEF 14A 2022: proxy statement for fiscal 2022
• Oncotelic Therapeutics, Inc. Form 4 2026OTLC Form 4 2026: insider trading filing for fiscal 2026
• Oncotelic Therapeutics, Inc. Form 4 2025OTLC Form 4 2025: insider trading filing for fiscal 2025
• Oncotelic Therapeutics, Inc. Form 4 2024OTLC Form 4 2024: insider trading filing for fiscal 2024
• Oncotelic Therapeutics, Inc. Form 4 2023OTLC Form 4 2023: insider trading filing for fiscal 2023
• Oncotelic Therapeutics, Inc. Form 4 2022OTLC Form 4 2022: insider trading filing for fiscal 2022
• Oncotelic Therapeutics, Inc. S-1 2026OTLC S-1 2026: registration statement for fiscal 2026
• Oncotelic Therapeutics, Inc. S-1 2025OTLC S-1 2025: registration statement for fiscal 2025
• Oncotelic Therapeutics, Inc. S-1 2024OTLC S-1 2024: registration statement for fiscal 2024
• Oncotelic Therapeutics, Inc. S-1 2023OTLC S-1 2023: registration statement for fiscal 2023
• Oncotelic Therapeutics, Inc. S-1 2022OTLC S-1 2022: registration statement for fiscal 2022
• Oncotelic Therapeutics, Inc. 13F 2026OTLC 13F 2026: institutional holdings for fiscal 2026
• Oncotelic Therapeutics, Inc. 13F 2025OTLC 13F 2025: institutional holdings for fiscal 2025
• Oncotelic Therapeutics, Inc. 13F 2024OTLC 13F 2024: institutional holdings for fiscal 2024
• Oncotelic Therapeutics, Inc. 13F 2023OTLC 13F 2023: institutional holdings for fiscal 2023
• Oncotelic Therapeutics, Inc. 13F 2022OTLC 13F 2022: institutional holdings for fiscal 2022

More companies